Work

Synergism between bosutinib (SKI-606) and the Chk1 inhibitor (PF-00477736) in highly imatinib-resistant BCR/ABL+ leukemia cells

Year: 2014

Type: article

Source: Leukemia Research

DOI: 10.1016/j.leukres.2014.10.009

Authors: Tri Nguyen, Elisa Hawkins, Akhil Kolluri, Maciej Kmieciak, Haeseong Park, Hui Lin, Steven Grant

Institutions: Virginia Commonwealth University, Virginia Commonwealth University Medical Center, VCU Massey Comprehensive Cancer Center

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Leukemia and Lymphoma Society, National Institutes of Health, National Cancer Institute

Awards: G1353051725, G1527479329, G2061303994, G3148123924, G364506074, G9000124875, Massey Cancer Center - Cancer Center Support Grant

OpenAlex ID: W2014042715

FWCI: 1.223

Cites: 39

Cited by: 17

Related to: 10